Codeine
Actifed, Ambenyl, Bromanyl, Codrix, Empracet, Fioricet, Papeine, Phenaphen, Phenergan, Pherazine, Prometh, Proval, Soma, Tuxarin, Tylenol (codeine) is a small molecule pharmaceutical. Codeine was first approved as Codeine, aspirin, apap formula no. 4 on 1982-01-01. It is used to treat cough and pain in the USA. The pharmaceutical is active against mu-type opioid receptor.
Download report
Favorite
Searched
Commercial
Trade Name
FDA
EMA
Combinations
Fioricet, Tuxarin (generic drugs available since 1982-01-01, discontinued: Actifed, Ambenyl, Bromanyl, Codrix, Empracet, Papeine, Phenaphen, Phenergan, Pherazine, Prometh, Proval, Soma, Tylenol)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acetaminophen
+
Butalbital
+
Caffeine
+
Codeine phosphate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FIORICET W/ CODEINE | Allergan | N-020232 RX | 1992-07-30 | 1 products, RLD, RS |
Aspirin
+
Butalbital
+
Caffeine
+
Codeine phosphate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FIORINAL W/CODEINE | Allergan | N-019429 DISCN | 1990-10-26 | 1 products, RLD |
Hide discontinued
Aspirin
+
Carisoprodol
+
Codeine phosphate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SOMA COMPOUND W/ CODEINE | Meda AB | N-012366 DISCN | 1983-07-11 | 1 products |
Hide discontinued
Bromodiphenhydramine hydrochloride
+
Codeine phosphate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AMBENYL | Forest Laboratories | N-009319 DISCN | 1984-01-10 | 1 products |
Hide discontinued
Chlorpheniramine maleate
+
Codeine phosphate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TUXARIN ER | MainPointe Pharmaceuticals | N-206323 RX | 2015-06-22 | 1 products |
Codeine phosphate
+
Phenylephrine hydrochloride
+
Promethazine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PHENERGAN VC W/ CODEINE | ANI PHARMS | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Hide discontinued
Codeine phosphate
+
Promethazine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PHENERGAN W/ CODEINE | ANI PHARMS | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Hide discontinued
Codeine phosphate
+
Pseudoephedrine hydrochloride
+
Triprolidine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACTIFED W/ CODEINE | GSK | N-012575 DISCN | 1984-04-04 | 1 products |
Hide discontinued
Codeine sulfate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CODEINE SULFATE | Hikma Pharmaceuticals | N-022402 RX | 2009-07-16 | 3 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
acetaminophen and codeine | ANDA | 2023-06-07 |
codrix | 2008-05-16 | |
extra strength tylenol severe cough plus sore throat night | OTC monograph final | 2023-04-07 |
fioricet | ANDA | 2021-01-01 |
phenergan | ANDA | 2022-12-01 |
promethazine hydrochloride | ANDA | 2023-06-08 |
triacin-c | ANDA | 2015-07-28 |
tuxarin | New Drug Application | 2021-11-04 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
cough | HP_0012735 | D003371 | R05 |
pain | EFO_0003843 | D010146 | R52 |
Agency Specific
FDA
EMA
No data
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AA: Natural opium alkaloid analgesics
— N02AA59: Codeine, combinations excl. psycholeptics
— N02AA79: Codeine, combinations with psycholeptics
— N02AJ: Opioids in combination with non-opioid analgesics
— N02AJ06: Codeine and paracetamol
— N02AJ07: Codeine and acetylsalicylic acid
— N02AJ08: Codeine and ibuprofen
— N02AJ09: Codeine and other non-opioid analgesics
R: Respiratory system drugs
— R05: Cough and cold preparations
— R05D: Cough suppressants, excl. combinations with expectorants
— R05DA: Opium alkaloids and derivatives, cough suppressants
— R05DA04: Codeine
HCPCS
Code | Description |
---|---|
J0745 | Injection, codeine phosphate, per 30 mg |
Clinical
Clinical Trials
1255 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postoperative pain | D010149 | G89.18 | 5 | 18 | 38 | 70 | 35 | 164 | |
Pain | D010146 | EFO_0003843 | R52 | 19 | 25 | 29 | 53 | 31 | 152 |
Healthy volunteers/patients | — | 39 | — | 2 | 5 | 9 | 55 | ||
Fever | D005334 | HP_0001945 | R50.9 | 3 | 5 | 10 | 12 | 5 | 33 |
Acute pain | D059787 | R52 | 2 | 2 | 10 | 13 | 5 | 32 | |
Analgesia | D000698 | 3 | 3 | 8 | 10 | 6 | 29 | ||
Migraine disorders | D008881 | EFO_0003821 | G43 | — | 6 | 6 | 10 | 3 | 24 |
Low back pain | D017116 | HP_0003419 | M54.5 | 1 | 2 | 7 | 9 | 5 | 24 |
Patent ductus arteriosus | D004374 | HP_0001643 | Q25.0 | 2 | 10 | 7 | 3 | 6 | 24 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | 2 | 5 | 9 | 4 | 21 |
Show 183 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | C90.0 | 2 | 4 | 1 | — | — | 7 | |
Dental pins | D003772 | — | 5 | 1 | — | — | 6 | ||
Covid-19 | D000086382 | U07.1 | — | 2 | 3 | — | 1 | 5 | |
Lupus nephritis | D008181 | EFO_0005761 | — | 2 | 3 | — | — | 5 | |
Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | 2 | 4 | — | — | 5 |
Head and neck neoplasms | D006258 | — | 1 | 2 | — | 1 | 4 | ||
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | 1 | — | 2 | 3 |
Respiratory insufficiency | D012131 | HP_0002093 | J96.9 | — | 1 | 1 | — | 1 | 3 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 1 | — | 2 | 3 |
Lymphoma | D008223 | C85.9 | — | 2 | 1 | — | — | 3 |
Show 77 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulpitis | D011671 | EFO_1001139 | K04.0 | — | 3 | — | — | 3 | 6 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 3 | 2 | — | — | — | 4 | |
Non-hodgkin lymphoma | D008228 | C85.9 | 2 | 3 | — | — | — | 4 | |
Cleft palate | D002972 | Q35 | — | 2 | — | — | 1 | 3 | |
Male breast neoplasms | D018567 | — | 1 | — | — | 2 | 3 | ||
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 3 | 1 | — | — | — | 3 | |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | 2 | 3 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 1 | 1 | — | — | 1 | 3 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | 1 | — | — | 2 | 3 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 2 | — | — | 1 | 3 |
Show 74 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | 1 | — | — | — | 2 | 3 | ||
Overweight | D050177 | E66.3 | 2 | — | — | — | 1 | 3 | |
Therapeutic equivalency | D013810 | 2 | — | — | — | — | 2 | ||
Ankle fractures | D064386 | S82.5 | 1 | — | — | — | 1 | 2 | |
Intervertebral disc degeneration | D055959 | HP_0008419 | 1 | — | — | — | 1 | 2 | |
Alpha 1-antitrypsin deficiency | D019896 | E88.01 | 1 | — | — | — | 1 | 2 | |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 2 | — | — | — | — | 2 |
Magnetic resonance imaging | D008279 | 1 | — | — | — | — | 1 | ||
Oral administration | D000284 | 1 | — | — | — | — | 1 | ||
Pure autonomic failure | D054970 | 1 | — | — | — | — | 1 |
Show 28 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Vitreoretinal surgery | D057586 | — | — | — | — | 3 | 3 | ||
Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | — | — | — | 3 | 3 |
Thyroidectomy | D013965 | — | — | — | — | 2 | 2 | ||
Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | — | — | — | — | 2 | 2 |
Intervertebral disc displacement | D007405 | EFO_1001800 | — | — | — | — | 2 | 2 | |
Feeding and eating disorders | D001068 | F50 | — | — | — | — | 2 | 2 | |
Female genital diseases | D005831 | EFO_0009549 | N85 | — | — | — | — | 2 | 2 |
Long-term memory | D057567 | — | — | — | — | 1 | 1 | ||
Short-term memory | D008570 | EFO_0004335 | — | — | — | — | 1 | 1 | |
Aspirin-induced asthma | D055963 | HP_0012042 | — | — | — | — | 1 | 1 |
Show 79 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CODEINE |
INN | paracetamol |
Description | Codeine is a morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties. It has a role as an opioid analgesic, an antitussive, an opioid receptor agonist, a prodrug, a xenobiotic, an environmental contaminant and a drug allergen. It is an organic heteropentacyclic compound and a morphinane alkaloid. It is functionally related to a morphine. It is a conjugate base of a codeine(1+). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314 |
Identifiers
PDB | — |
CAS-ID | 76-57-3 |
RxCUI | 1545976 |
ChEMBL ID | CHEMBL485 |
ChEBI ID | 16714 |
PubChem CID | 5284371 |
DrugBank | DB00318 |
UNII ID | 362O9ITL9D (ChemIDplus, GSRS) |
Target
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 61,591 documents
View more details
Safety
Black-box Warning
Black-box warning for: Acetaminophen and codeine, Fioricet, Promethazine hydrochloride, Triacin-c, Tuxarin
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,635 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more